18 phenotypes from 2 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cd209btm1.1Cfg/Cd209btm1.1Cfg involves: C57BL/6	abnormal glomerular mesangium morphology	J:217719
	decreased circulating bilirubin level	J:217719
	decreased mature B cell number	J:217719
	impaired macrophage phagocytosis	J:288225
	increased eosinophil cell number	J:288225
	increased IgG2b level	J:217719
	increased IgG3 level	J:217719
	increased IgM level	J:217719
	increased macrophage cell number	J:217719
	increased susceptibility to bacterial infection	J:288225
	urinary bladder inflammation	J:288225
Cd209btm1.1Cfg/Cd209btm1.1Cfg involves: C57BL/6 * C57BL/6J	normal immune system phenotype	J:153503
Cd209btm1Anjm/Cd209btm1Anjm B6.129P2-Cd209btm1Anjm	decreased interleukin-1 beta secretion	J:159646
	decreased interleukin-18 secretion	J:159646
	decreased susceptibility to endotoxin shock	J:159646
	decreased susceptibility to induced colitis	J:159646
	increased susceptibility to bacterial infection induced morbidity/mortality	J:94698
Cd209btm1Anjm/Cd209btm1Anjm C.129P2-Cd209btm1Anjm	normal immune system phenotype	J:143766
Cd209btm1Anjm/Cd209btm1Anjm involves: 129P2/OlaHsd * BALB/c	normal immune system phenotype	J:209808
Cd209btm1Anjm/Cd209btm1Anjm involves: 129P2/OlaHsd * C57BL/6	abnormal macrophage physiology	J:94698
	impaired macrophage phagocytosis	J:94698
	increased susceptibility to bacterial infection	J:94698
	increased susceptibility to bacterial infection induced morbidity/mortality	J:94698